Wednesday, November 4, 2026||
MultiKhabarMultiKhabar

Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr

Share:WhatsAppFacebookX (Twitter)Telegram
Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr
Photo / Coverage: The Hindu Business Line
EXECUTIVE SUMMARY

The total revenue of the Hyderabad-based company grew 24 per cent

Key Takeaways

  • Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr.
  • The total revenue of the Hyderabad-based company grew 24 per cent The total revenue of the Hyderabad-based company grew 24 per cent

The total revenue of the Hyderabad-based company grew 24 per cent

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Hindu Business Line

Visit Publisher Site →

Related News

🇮🇳 India
New entrants eat into SIP inflows of listed Mutual funds
Economy & Business20m ago

New entrants eat into SIP inflows of listed Mutual funds

The monthly SIP inflows of ICICI Prudential AMC peaked to ₹5,104 crore in March quarter and dipped to ₹4,872 crore in June quarter and further to ₹4,672 crore in September quarter

The Hindu Business Line
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play